309 related articles for article (PubMed ID: 19164806)
1. Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.
Hlawaty H; Jacob MP; Louedec L; Letourneur D; Brink C; Michel JB; Feldman L; Bäck M
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):518-24. PubMed ID: 19164806
[TBL] [Abstract][Full Text] [Related]
2. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia.
Bäck M; Bu DX; Bränström R; Sheikine Y; Yan ZQ; Hansson GK
Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17501-6. PubMed ID: 16293697
[TBL] [Abstract][Full Text] [Related]
4. Reversion-inducing-cysteine-rich protein with Kazal motif is involved in intimal hyperplasia in carotid arteries: a new insight in the prevention of restenosis after vascular angioplasty.
Liu J; Chi D; Lu H; Zhang T; Yamakawa T
Ann Vasc Surg; 2015 Aug; 29(6):1293-9. PubMed ID: 26004948
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
Bot I; de Vries H; Korporaal SJ; Foks AC; Bot M; van Veldhoven J; Ter Borg MN; van Santbrink PJ; van Berkel TJ; Kuiper J; Ijzerman AP
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2197-205. PubMed ID: 22743060
[TBL] [Abstract][Full Text] [Related]
6. Anplag, a selective 5-HT2 receptor antagonist, reduces stenosis induced by balloon injury in the hypercholesterolaemic rabbit.
Origuchi N; Shigematsu H; Muto T
Int Angiol; 1997 Sep; 16(3):204-9. PubMed ID: 9405017
[TBL] [Abstract][Full Text] [Related]
7. Local matrix metalloproteinase 2 gene knockdown in balloon-injured rabbit carotid arteries using nonviral-small interfering RNA transfection.
Hlawaty H; San Juan A; Jacob MP; Vranckx R; Letourneur D; Feldman LJ
J Gene Med; 2009 Jan; 11(1):92-9. PubMed ID: 19040207
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor α and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells.
Chieng-Yane P; Bocquet A; Létienne R; Bourbon T; Sablayrolles S; Perez M; Hatem SN; Lompré AM; Le Grand B; David-Dufilho M
J Pharmacol Exp Ther; 2011 Mar; 336(3):643-51. PubMed ID: 21139058
[TBL] [Abstract][Full Text] [Related]
9. Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma.
Joner M; Morimoto K; Kasukawa H; Steigerwald K; Merl S; Nakazawa G; John MC; Finn AV; Acampado E; Kolodgie FD; Gold HK; Virmani R
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1960-6. PubMed ID: 18688017
[TBL] [Abstract][Full Text] [Related]
10. A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening.
Islam MM; Franco CD; Courtman DW; Bendeck MP
Am J Pathol; 2003 Oct; 163(4):1557-66. PubMed ID: 14507662
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia.
Kuzuya M; Kanda S; Sasaki T; Tamaya-Mori N; Cheng XW; Itoh T; Itohara S; Iguchi A
Circulation; 2003 Sep; 108(11):1375-81. PubMed ID: 12939223
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFkappaB and E2F in a rabbit model.
Miyake T; Aoki M; Morishita R
Cardiovasc Res; 2008 Sep; 79(4):706-14. PubMed ID: 18515844
[TBL] [Abstract][Full Text] [Related]
13. Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition.
Wu BJ; Li Y; Ong KL; Sun Y; Shrestha S; Hou L; Johns D; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2333-2341. PubMed ID: 29025709
[TBL] [Abstract][Full Text] [Related]
14. Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells.
Bellosta S; Baetta R; Canavesi M; Comparato C; Granata A; Monetti M; Cairoli F; Eberini I; Puglisi L; Corsini A
Pharmacol Res; 2007 Aug; 56(2):160-7. PubMed ID: 17582780
[TBL] [Abstract][Full Text] [Related]
15. Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits.
Narita H; Chen S; Komori K; Kadomatsu K
J Vasc Surg; 2008 Jun; 47(6):1322-9. PubMed ID: 18353604
[TBL] [Abstract][Full Text] [Related]
16. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice.
Chadjichristos CE; Matter CM; Roth I; Sutter E; Pelli G; Lüscher TF; Chanson M; Kwak BR
Circulation; 2006 Jun; 113(24):2835-43. PubMed ID: 16769907
[TBL] [Abstract][Full Text] [Related]
17. MMP-2 and MMP-9 alteration in response to collaring in rabbits: the effects of endothelin receptor antagonism.
Reel B; Oktay G; Ozkal S; Islekel H; Ozer E; Ozsarlak-Sozer G; Cavdar Z; Akhisaroglu ST; Kerry Z
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):292-301. PubMed ID: 19734325
[TBL] [Abstract][Full Text] [Related]
18. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
[TBL] [Abstract][Full Text] [Related]
19. VEGF-A, VEGF-D and VEGF-D(DeltaNDeltaC) induced intimal hyperplasia in carotid arteries.
Bhardwaj S; Roy H; Heikura T; Ylä-Herttuala S
Eur J Clin Invest; 2005 Nov; 35(11):669-76. PubMed ID: 16269016
[TBL] [Abstract][Full Text] [Related]
20. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R
Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
